The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The High-Throughput Screening Services Market Projected To Expand During 2026–2030?

The high-throughput screening services market has experienced significant growth recently. This market is projected to expand from $23.02 billion in 2025 to $25.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.0%. Historically, this expansion has been driven by factors such as the rise in pharmaceutical research and development (R&D) endeavors, increased application of combinatorial chemistry libraries, the integration of automated liquid handling systems, a heightened need for swift target identification, and the accessibility of extensive compound libraries.

The high-throughput screening services market is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $39.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.2%. This projected growth is attributable to several factors, including heightened investments in precision drug discovery, a growing emphasis on biologics and intricate targets, the broadening of personalized medicine research, an expanding adoption of AI-assisted screening workflows, and increased outsourcing of screening services to Contract Research Organizations (CROs). Key trends foreseen during this period encompass the wider deployment of automated robotic screening platforms, a surging demand for ultra-high-throughput screening services, the increasing uptake of cell-based and label-free assays, the expansion of AI-driven data analysis within drug discovery, and a sharpened focus on expediting hit-to-lead identification processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33169&type=smp

What Are The Main Drivers Accelerating The Growth Of The High-Throughput Screening Services Market?

The escalating occurrence of chronic and complex diseases is projected to drive the expansion of the high-throughput screening services market. These conditions are characterized as long-term ailments that involve various biological pathways, persist for extended durations, and typically demand continuous management rather than short-term treatment. The growth in their prevalence is largely due to an aging global population, lifestyle-related risk factors, and improved disease detection methods, which collectively increase the burden on healthcare infrastructure and stimulate the demand for innovative therapeutic solutions. High-throughput screening (HTS) services support the investigation of chronic and complex diseases by enabling the rapid and simultaneous evaluation of a large volume of compounds against biological targets. This capability accelerates the early stages of drug discovery, enhances target identification, and facilitates the development of more effective treatments for multifaceted and enduring conditions. For instance, in April 2025, information from the Centers for Disease Control and Prevention (CDC), a US-based federal agency, revealed that approximately 76.4% of adults in the United States, representing more than 194 million people, reported having at least one chronic condition in 2023, while 51.4% (around 131 million people) reported multiple chronic conditions. Thus, the increasing prevalence of chronic and complex diseases is a significant catalyst for the growth of the high-throughput screening services market.

What Key Segment Areas Are Included In The High-Throughput Screening Services Market Assessment?

The high-throughput screening services market covered in this report is segmented –

1) By Products And Services: Instruments; Reagents And Kits; Services

2) By Technology: Ultra-high-throughput Screening; Cell-based Assays; Lab-on-a-chip; Label-free Technology

3) By Application: Target Identification; Primary Screening; Toxicology

4) By End User: Pharmaceutical And Biotechnology Firms; Academia And Research Institutes; Contract Research Organizations

Subsegments:

1) By Instruments: Automated Screening Systems; Liquid Handling Systems; Detection And Imaging Systems; Data Acquisition Systems

2) By Reagents And Kits: Assay Reagents; Screening Kits; Cell Based Reagents; Detection Reagents

3) By Services: Assay Development And Optimization Services; Primary Screening Services; Hit Confirmation And Validation; Data Analysis And Bioinformatics Support; Specialized Screens; Project Management And Reporting

Which Trends Are Guiding The Development Of The High-Throughput Screening Services Market?

Major companies engaged in the high-throughput screening services market are prioritizing innovation in miniaturized and high-density assays, including those offering ultra-high screening speed with up to 27 detection channels. This focus aims to enable faster, large-scale multiparametric analysis and accelerate drug discovery workflows. Ultra-high screening speed with up to 27 detection channels refers to the capacity to quickly analyze numerous biological parameters concurrently, thereby boosting data output and efficiency in high-throughput screening studies. As an illustration, in May 2024, Evotec SE, a Germany-based company providing drug discovery and development services, introduced comprehensive high-throughput screening services as an element of its integrated early discovery platform. Evotec executes large-scale biochemical and cell-based HTS campaigns utilizing highly automated, miniaturized assay systems and advanced data analytics. The company assists pharmaceutical and biotechnology partners by swiftly identifying hit compounds and optimizing lead selection, consequently accelerating early-stage drug discovery programs.

Which Industry Players Are Present In The High-Throughput Screening Services Market?

Major companies operating in the high-throughput screening services market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Incorporated, Eurofins Scientific SE, Charles River Laboratories International Inc., Revvity Inc., Bio-Rad Laboratories Inc., Hamilton Company, Tecan Group Ltd., GenScript Biotech Corporation, Promega Corporation, Molecular Devices LLC, ShanghAI Medicilon Inc., Sygnature Discovery Limited, Selvita S.A., Cayman Chemical Company, Creative Bioarray Inc., Axxam S.p.A., Axcelead Inc., Creative Biolabs Inc., Enamine Ltd., Aurora Biomed Inc.

Access The Complete High-Throughput Screening Services Market Report:

https://www.thebusinessresearchcompany.com/report/high-throughput-screening-services-market-report

Which Region Has The Strongest Presence In The High-Throughput Screening Services Market?

North America was the largest region in the high-throughput screening services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-throughput screening services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized High-Throughput Screening Services Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model